Return On Equity of Akero Therapeutics, Inc. from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Akero Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • Akero Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -31%, a 5.7% increase year-over-year.
  • Akero Therapeutics, Inc. annual Return On Equity for 2024 was -32%, a 8.2% decline from 2023.
  • Akero Therapeutics, Inc. annual Return On Equity for 2023 was -30%, a 36% increase from 2022.
  • Akero Therapeutics, Inc. annual Return On Equity for 2022 was -46%, a 3.9% increase from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Akero Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -31% +2% +5.7% 01 Jul 2025 30 Sep 2025
Q2 2025 -32% -2% -6.8% 01 Apr 2025 30 Jun 2025
Q1 2025 -32% -4% -15% 01 Jan 2025 31 Mar 2025
Q4 2024 -32% -2% -8.2% 01 Oct 2024 31 Dec 2024
Q3 2024 -33% -6% -25% 01 Jul 2024 30 Sep 2024
Q2 2024 -30% -1% -1.9% 01 Apr 2024 30 Jun 2024
Q1 2024 -28% +12% +30% 01 Jan 2024 31 Mar 2024
Q4 2023 -30% +17% +36% 01 Oct 2023 31 Dec 2023
Q3 2023 -26% +34% +57% 01 Jul 2023 30 Sep 2023
Q2 2023 -29% +38% +56% 01 Apr 2023 30 Jun 2023
Q1 2023 -40% +21% +35% 01 Jan 2023 31 Mar 2023
Q4 2022 -46% +2% +3.9% 01 Oct 2022 31 Dec 2022
Q3 2022 -60% -18% -42% 01 Jul 2022 30 Sep 2022
Q2 2022 -67% -29% -77% 01 Apr 2022 30 Jun 2022
Q1 2022 -61% -24% -65% 01 Jan 2022 31 Mar 2022
Q4 2021 -48% -7% -17% 01 Oct 2021 31 Dec 2021
Q3 2021 -42% -2% -3.9% 01 Jul 2021 30 Sep 2021
Q2 2021 -38% +10% +22% 01 Apr 2021 30 Jun 2021
Q1 2021 -37% 0% -0.52% 01 Jan 2021 31 Mar 2021
Q4 2020 -41% +5% +11% 01 Oct 2020 31 Dec 2020
Q3 2020 -41% +141% +78% 01 Jul 2020 30 Sep 2020
Q2 2020 -48% +1156% +96% 01 Apr 2020 30 Jun 2020
Q1 2020 -37% -278% -115% 01 Jan 2020 31 Mar 2020
Q4 2019 -47% -395% -113% 01 Oct 2019 31 Dec 2019
Q3 2019 -182% 01 Jul 2019 30 Sep 2019
Q2 2019 -1204% 01 Apr 2019 30 Jun 2019
Q1 2019 241% 01 Jan 2019 31 Mar 2019
Q4 2018 349% 01 Oct 2018 31 Dec 2018

Akero Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -32% -2% -8.2% 01 Jan 2024 31 Dec 2024
2023 -30% +17% +36% 01 Jan 2023 31 Dec 2023
2022 -46% +2% +3.9% 01 Jan 2022 31 Dec 2022
2021 -48% -7% -17% 01 Jan 2021 31 Dec 2021
2020 -41% +5% +11% 01 Jan 2020 31 Dec 2020
2019 -47% -395% -113% 01 Jan 2019 31 Dec 2019
2018 349% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.